ESSENTIAL PHOSPHOLIPID IN METABOLIC ASSOCIATED FATTY LIVER DISEASE

Clinical trials for ESSENTIAL PHOSPHOLIPID IN METABOLIC ASSOCIATED FATTY LIVER DISEASE explained in plain language.

Never miss a new study

Get alerted when new ESSENTIAL PHOSPHOLIPID IN METABOLIC ASSOCIATED FATTY LIVER DISEASE trials appear

Sign up with your email to follow new studies for ESSENTIAL PHOSPHOLIPID IN METABOLIC ASSOCIATED FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Fatty liver fight: soy extract vs. betaine in Head-to-Head trial

Disease control Not yet recruiting

This study aims to see which of two dietary supplements works better to reduce fat in the liver for people with metabolic-associated fatty liver disease (MAFLD). It will involve 200 adults diagnosed with fatty liver. Researchers will measure changes in liver fat using medical ima…

Matched conditions: ESSENTIAL PHOSPHOLIPID IN METABOLIC ASSOCIATED FATTY LIVER DISEASE

Sponsor: Assiut University • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

ESSENTIAL PHOSPHOLIPID IN METABOLIC ASSOCIATED FATTY LIVER DISEASE

Get alerted when new ESSENTIAL PHOSPHOLIPID IN METABOLIC ASSOCIATED FATTY LIVER DISEASE trials appear

Fatty liver fight: soy extract vs. betaine in Head-to-Head trial